BSE Live
Oct 30, 16:01Prev. Close
530.65
Open Price
535.15
Bid Price (Qty.)
527.50 (1)
Offer Price (Qty.)
539.00 (47)
NSE Live
Oct 30, 15:45Prev. Close
532.90
Open Price
530.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
532.40 (18)
| Key Financial Ratios of Lincoln Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 31.11 | |
| Diluted EPS (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 31.11 | |
| Cash EPS (Rs.) | 47.55 | 51.89 | 40.97 | 38.66 | 34.91 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 335.34 | 295.98 | 250.86 | 216.12 | 187.85 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 335.34 | 295.98 | 250.86 | 216.12 | 187.85 | |
| Revenue from Operations/Share (Rs.) | 311.15 | 289.84 | 254.78 | 235.71 | 212.09 | |
| PBDIT/Share (Rs.) | 61.89 | 67.07 | 55.76 | 52.66 | 46.42 | |
| PBIT/Share (Rs.) | 55.45 | 61.76 | 51.18 | 48.62 | 42.64 | |
| PBT/Share (Rs.) | 54.51 | 61.03 | 50.17 | 47.90 | 41.86 | |
| Net Profit/Share (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 31.12 | |
| NP After MI And SOA / Share (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 31.11 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 19.89 | 23.13 | 21.88 | 22.34 | 21.88 | |
| PBIT Margin (%) | 17.82 | 21.30 | 20.08 | 20.62 | 20.10 | |
| PBT Margin (%) | 17.51 | 21.05 | 19.68 | 20.32 | 19.73 | |
| Net Profit Margin (%) | 13.21 | 16.07 | 14.28 | 14.69 | 14.67 | |
| NP After MI And SOA Margin (%) | 13.21 | 16.07 | 14.28 | 14.69 | 14.66 | |
| Return on Networth/Equity (%) | 12.25 | 15.73 | 14.50 | 16.02 | 16.58 | |
| Return on Capital Employed (%) | 16.07 | 20.34 | 19.89 | 21.94 | 22.10 | |
| Return on Assets (%) | 10.33 | 13.32 | 12.41 | 12.97 | 13.54 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.83 | 0.90 | 0.91 | 0.95 | 92.34 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 4.71 | 4.84 | 5.08 | 3.90 | 4.17 | |
| Quick Ratio (X) | 3.97 | 4.01 | 4.11 | 3.10 | 3.53 | |
| Inventory Turnover Ratio (X) | 2.75 | 2.73 | 2.48 | 2.66 | 9.10 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 3.22 | 4.12 | 4.32 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 2.89 | 3.66 | 3.87 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 96.78 | 95.88 | 95.68 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 97.11 | 96.34 | 96.13 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 65.84 | 91.70 | 55.01 | 72.68 | 54.60 | |
| Interest Coverage Ratios (Post Tax) (%) | 65.84 | 91.70 | 55.01 | 72.68 | 54.60 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,082.31 | 1,159.77 | 646.08 | 574.49 | 436.11 | |
| EV/Net Operating Revenue (X) | 1.74 | 2.00 | 1.27 | 1.22 | 1.03 | |
| EV/EBITDA (X) | 8.73 | 8.63 | 5.79 | 5.45 | 4.70 | |
| MarketCap/Net Operating Revenue (X) | 1.77 | 2.02 | 1.33 | 1.32 | 1.06 | |
| Retention Ratios (%) | 0.00 | 96.77 | 95.87 | 95.67 | 0.00 | |
| Price/BV (X) | 1.64 | 1.98 | 1.35 | 1.44 | 1.20 | |
| Price/Net Operating Revenue | 1.77 | 2.02 | 1.33 | 1.32 | 1.06 | |
| Earnings Yield | 0.07 | 0.08 | 0.11 | 0.11 | 0.14 | 
07.08.2025
Lincoln Pharma Standalone June 2025 Net Sales at Rs 154.07 crore, up 4.61% Y-o-Y
24.06.2025
Lincoln Pharma Consolidated March 2025 Net Sales at Rs 168.18 crore, up 18.03% Y-o-Y
04.03.2025
Lincoln Pharma Consolidated December 2024 Net Sales at Rs 146.55 crore, up 0.07% Y-o-Y
28.11.2024
Lincoln Pharma Consolidated September 2024 Net Sales at Rs 161.21 crore, up 3.35% Y-o-Y
07.08.2025
Lincoln Pharma Standalone June 2025 Net Sales at Rs 154.07 crore, up 4.61% Y-o-Y
24.06.2025
Lincoln Pharma Consolidated March 2025 Net Sales at Rs 168.18 crore, up 18.03% Y-o-Y
04.03.2025
Lincoln Pharma Consolidated December 2024 Net Sales at Rs 146.55 crore, up 0.07% Y-o-Y
28.11.2024
Lincoln Pharma Consolidated September 2024 Net Sales at Rs 161.21 crore, up 3.35% Y-o-Y